ES2189978T3 - Compuestos de acido 2-aminocarboxilico sustituidos con 3-alcoxiisoxazol-4-ilo. - Google Patents
Compuestos de acido 2-aminocarboxilico sustituidos con 3-alcoxiisoxazol-4-ilo.Info
- Publication number
- ES2189978T3 ES2189978T3 ES97942821T ES97942821T ES2189978T3 ES 2189978 T3 ES2189978 T3 ES 2189978T3 ES 97942821 T ES97942821 T ES 97942821T ES 97942821 T ES97942821 T ES 97942821T ES 2189978 T3 ES2189978 T3 ES 2189978T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- ilo
- disease
- rent
- renting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000003257 excitatory amino acid Substances 0.000 abstract 2
- 150000002430 hydrocarbons Chemical class 0.000 abstract 2
- MGRVRXRGTBOSHW-UHFFFAOYSA-N (aminomethyl)phosphonic acid Chemical compound NCP(O)(O)=O MGRVRXRGTBOSHW-UHFFFAOYSA-N 0.000 abstract 1
- 102000003678 AMPA Receptors Human genes 0.000 abstract 1
- 108090000078 AMPA Receptors Proteins 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 abstract 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 230000004075 alteration Effects 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 230000001037 epileptic effect Effects 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical class [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
LA INVENCION SE REFIERE A DERIVADOS DEL ACIDO 2 AMINOCARBOXILICO SUSTITUIDOS POR 3 - ALCOXIISOXAZOL - 4 - ILO Y A ANALOGOS AZUFRADOS DE LOS MISMOS, LOS CUALES ESTAN REPRESENTADOS POR LA FORMULA GENERAL (I) O (II), DONDE R 1 ES HIDROGENO, ALQUILO, ALQUENILO, ALQUINILO, CICLOALQU(EN)ILO, CICLOALQU(EN)IL - ALQU(EN/IN)ILO, O FENIL - ALQU(EN/IN)ILO OPCIONALMENTE SUSTITUIDO; A ES UN ENLACE O UN GRUPO ESPACIADOR HIDROCARBONADO; B ES UN GRUPO - CR A (NR B R C ) COOR 5 , DONDE R A - R C SON INDEPENDIENTEMENTE HIDROGENO O ALQUILO; Y R 5 SE DEFINE COMO R 1 O COMO PIVALOILOXIMETILO; O B ES UN GRUPO DE FORMULA (III), DONDE R 2 , R 3 Y R4 SE SELECCIONAN INDEPENDIENTEMENTE A PARTIR DE HIDROGEN O, UN GRUPO HIDROCARBONADO NO AROMATICO, FENIL - Y TIENIL - ALQUILO Y UN GRUPO HETEROALIFATICO; O R 3 Y R 4 ESTAN CONECTADOS ENTRE SI, FORMANDO UN GRUPO ALQUILENO, ALQUENILENO O ALQUINILENO; O R 4 Y R 2 ESTAN CONECTADOS FORMANDO UN GRUPO ALQUILENO, ALQUENILENO O ALQUINILENO, OPCIONALMENTE SUSTITUIDO POR HIDROXILO OMETILO, O FORMANDO CH 2 - O - C H 2 ; E ES COOR 6 , DONDE R 6 SE DEFINE COMO R SUB,5 , O E ES TETRAZOLILO O TRIAZOLILO; X ES O O S; E Y ES O O S. DICHOS COMPUESTOS SON AMINOACIDOS EXCITATORIOS (EAA), ESPECIALMENTE LIGANDOS DE RECEPTORES AMPA Y/O NMDA, UTILES EN EL TRATAMIENTO DE LA ISQUEMIA CEREBRAL, ENFERMEDAD DE HUNTINGTON, ALTERACIONES EPILEPTICAS, ENFERMEDAD DE PARKINSON, ENFERMEDAD DE ALZHEIMER, ESQUIZOFRENIA, DOLOR, DEPRESION Y ANSIEDAD.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK109296 | 1996-10-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2189978T3 true ES2189978T3 (es) | 2003-07-16 |
Family
ID=8100908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97942821T Expired - Lifetime ES2189978T3 (es) | 1996-10-04 | 1997-10-03 | Compuestos de acido 2-aminocarboxilico sustituidos con 3-alcoxiisoxazol-4-ilo. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6200999B1 (es) |
| EP (1) | EP0934286B1 (es) |
| JP (1) | JP2001501630A (es) |
| KR (1) | KR20000048908A (es) |
| CN (1) | CN1238766A (es) |
| AR (1) | AR008880A1 (es) |
| AT (1) | ATE230734T1 (es) |
| AU (1) | AU733004B2 (es) |
| BG (1) | BG103348A (es) |
| BR (1) | BR9712198A (es) |
| CA (1) | CA2268028C (es) |
| CZ (1) | CZ116899A3 (es) |
| DE (1) | DE69718338T2 (es) |
| EA (1) | EA001625B1 (es) |
| ES (1) | ES2189978T3 (es) |
| HU (1) | HUP0000084A3 (es) |
| IL (1) | IL129135A0 (es) |
| IS (1) | IS5009A (es) |
| NO (1) | NO312961B1 (es) |
| NZ (1) | NZ334798A (es) |
| PL (1) | PL332553A1 (es) |
| SK (1) | SK42899A3 (es) |
| TR (1) | TR199900724T2 (es) |
| UA (1) | UA52698C2 (es) |
| WO (1) | WO1998015542A1 (es) |
| ZA (1) | ZA978877B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA73749C2 (en) * | 1999-11-01 | 2005-09-15 | Diarylenines | |
| DE60122176T2 (de) * | 2000-09-15 | 2007-07-05 | Vertex Pharmaceuticals Inc., Cambridge | Isoxazole und ihre verwendung als erk-inhibitoren |
| US20040106794A1 (en) * | 2001-04-16 | 2004-06-03 | Schering Corporation | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| UA78529C2 (en) | 2001-10-10 | 2007-04-10 | Wyeth Corp | Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain |
| US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
| DE602004029146D1 (de) | 2003-04-09 | 2010-10-28 | Wyeth Llc | Derivate von 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkylphosphonsäure und deren verwendung als n-methyl-d-aspartat- (nmda-) rezeptorantagonisten |
| TW200514775A (en) | 2003-10-22 | 2005-05-01 | Wyeth Corp | Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof |
| BRPI0617306A2 (pt) * | 2005-10-11 | 2011-07-19 | Hoffmann La Roche | derivados de isoxazol |
| GB2470495B (en) * | 2008-01-16 | 2012-12-26 | Biotechnology Res Corp Ltd | Oxazolidine derivatives as NMDA antagonists |
| EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
| TW201609719A (zh) | 2014-05-28 | 2016-03-16 | 美國禮來大藥廠 | 作為ＴＡＲＰ－γ８依賴性ＡＭＰＡ受體拮抗劑之６－經取代－３Ｈ－１，３－苯并噻唑－２－酮化合物 |
| BR112018013541B1 (pt) * | 2016-01-21 | 2021-12-21 | Agro-Kanesho Co., Ltd. | Método para produzir um derivado do éster benzílico do ácido 2-aminonicotínico |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2042336A1 (en) | 1990-05-11 | 1991-11-12 | Mitsuo Nagano | Piperidyloxy-and quinuclidinyloxy-isoxazole, derivatives, their preparation and their therapeutic use |
| AU678186B2 (en) | 1992-10-23 | 1997-05-22 | Merck Sharp & Dohme Limited | Dopamine receptor subtype ligands |
| DK124393D0 (da) * | 1993-11-03 | 1993-11-03 | Lundbeck & Co As H | Compounds |
-
1997
- 1997-03-10 UA UA99042300A patent/UA52698C2/uk unknown
- 1997-10-03 HU HU0000084A patent/HUP0000084A3/hu unknown
- 1997-10-03 KR KR1019990702938A patent/KR20000048908A/ko not_active Ceased
- 1997-10-03 BR BR9712198-3A patent/BR9712198A/pt unknown
- 1997-10-03 ES ES97942821T patent/ES2189978T3/es not_active Expired - Lifetime
- 1997-10-03 TR TR1999/00724T patent/TR199900724T2/xx unknown
- 1997-10-03 PL PL97332553A patent/PL332553A1/xx unknown
- 1997-10-03 EA EA199900358A patent/EA001625B1/ru not_active IP Right Cessation
- 1997-10-03 CA CA002268028A patent/CA2268028C/en not_active Expired - Fee Related
- 1997-10-03 NZ NZ334798A patent/NZ334798A/en unknown
- 1997-10-03 AR ARP970104586A patent/AR008880A1/es not_active Application Discontinuation
- 1997-10-03 IL IL12913597A patent/IL129135A0/xx unknown
- 1997-10-03 SK SK428-99A patent/SK42899A3/sk unknown
- 1997-10-03 ZA ZA9708877A patent/ZA978877B/xx unknown
- 1997-10-03 WO PCT/DK1997/000426 patent/WO1998015542A1/en not_active Ceased
- 1997-10-03 DE DE69718338T patent/DE69718338T2/de not_active Expired - Fee Related
- 1997-10-03 CN CN97180167A patent/CN1238766A/zh active Pending
- 1997-10-03 JP JP10517096A patent/JP2001501630A/ja active Pending
- 1997-10-03 AT AT97942821T patent/ATE230734T1/de not_active IP Right Cessation
- 1997-10-03 US US09/269,356 patent/US6200999B1/en not_active Expired - Fee Related
- 1997-10-03 AU AU44517/97A patent/AU733004B2/en not_active Ceased
- 1997-10-03 CZ CZ991168A patent/CZ116899A3/cs unknown
- 1997-10-03 EP EP97942821A patent/EP0934286B1/en not_active Expired - Lifetime
-
1999
- 1999-03-20 BG BG103348A patent/BG103348A/xx unknown
- 1999-03-23 IS IS5009A patent/IS5009A/is unknown
- 1999-03-30 NO NO19991561A patent/NO312961B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2268028A1 (en) | 1998-04-16 |
| HUP0000084A3 (en) | 2001-12-28 |
| EA199900358A1 (ru) | 1999-10-28 |
| NZ334798A (en) | 2000-06-23 |
| TR199900724T2 (xx) | 1999-06-21 |
| KR20000048908A (ko) | 2000-07-25 |
| AR008880A1 (es) | 2000-02-23 |
| EP0934286A1 (en) | 1999-08-11 |
| EP0934286B1 (en) | 2003-01-08 |
| NO991561L (no) | 1999-06-04 |
| CZ116899A3 (cs) | 1999-09-15 |
| NO312961B1 (no) | 2002-07-22 |
| HUP0000084A2 (hu) | 2000-06-28 |
| US6200999B1 (en) | 2001-03-13 |
| SK42899A3 (en) | 1999-08-06 |
| ZA978877B (en) | 1998-04-17 |
| CA2268028C (en) | 2003-03-18 |
| AU733004B2 (en) | 2001-05-03 |
| NO991561D0 (no) | 1999-03-30 |
| WO1998015542A1 (en) | 1998-04-16 |
| AU4451797A (en) | 1998-05-05 |
| UA52698C2 (uk) | 2003-01-15 |
| PL332553A1 (en) | 1999-09-13 |
| BR9712198A (pt) | 1999-08-31 |
| CN1238766A (zh) | 1999-12-15 |
| IS5009A (is) | 1999-03-23 |
| ATE230734T1 (de) | 2003-01-15 |
| EA001625B1 (ru) | 2001-06-25 |
| BG103348A (en) | 1999-11-30 |
| IL129135A0 (en) | 2000-02-17 |
| DE69718338T2 (de) | 2003-10-16 |
| JP2001501630A (ja) | 2001-02-06 |
| DE69718338D1 (de) | 2003-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2189978T3 (es) | Compuestos de acido 2-aminocarboxilico sustituidos con 3-alcoxiisoxazol-4-ilo. | |
| EA200300428A1 (ru) | Антагонисты метаботропных рецепторов глутамата | |
| DE69628051D1 (de) | Phenylethanolamin-verbindungen und ihre anwendung als beta3 agonisten, verfahren zu ihrer herstellung und zwischenprodukte ihrer herstellung | |
| PT96857A (pt) | Processo para a preparacao de oxetanonas | |
| PE51097A1 (es) | Nuevos taxoides, su preparacion y composiciones farmaceuticas que los contienen | |
| DE69817542D1 (de) | Verfahren zur herstellung von olefincopolymeren mittels verbrückten bis(arylamido) katalysatorverbindungen von übergangsmetallen der gruppe 4 | |
| DE50308114D1 (de) | Verfahren zur herstellung von 6-alkoxy-(6h)-dibenz(c,e)(1,2)-oxaphosphorinen | |
| ATE407127T1 (de) | Verfahren zur herstellung von beraprost und dessen salzen | |
| DE3767993D1 (de) | Verfahren zur herstellung von thienylaethylaminen, und mittels des verfahrens hergestellte dithienylaethylamine. | |
| MX9200206A (es) | 1,2,3,4- TETRAHIDROCICLOPENT (b) INDOLES SUSBSTITUIDOS, 1,2,3,3a-4,8a- HEXAHIDROCICLOPENT (b) INDOLES Y COMPUESTOS RELACIONADOS, COMPUESTOS INTERMEDIOS Y UN PROCEDIMIENTO PARA LA PREPARACIONDE LOS MISMOS Y SU USO COMO MEDICAMENTOS. | |
| CO4700282A1 (es) | Compuestos | |
| BR9911250A (pt) | Processo para preparação de compostos | |
| EA200200611A1 (ru) | Новые тетрагидропиридины, способ их получения и содержащие их фармацевтические композиции | |
| EA199600007A3 (ru) | Новые трициклические производные, способ их получения, способы получения оптически активных или рацемических колхицина и тиоколхицина, их аналогов или производных с использованием трициклических соединений и промежуточные продукты синтеза | |
| DE69820481D1 (de) | Verfahren zur herstellung von cholecalciferol-derivaten und zwischenverbindungen | |
| ATE372332T1 (de) | Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga | |
| ATE310735T1 (de) | Verfahren zur herstellung von spirocyclischen tetronsäurederivaten | |
| ATE414070T1 (de) | Verfahren zur herstellung von optisch aktiven 2,4-dihydrobenzofuranverbindungen | |
| ATE168688T1 (de) | Verfahren zur herstellung von sulfonylharnstoffderivaten | |
| EA200500032A1 (ru) | Производные ацилоксипирролидина и их применение в качестве лигандов v1b или v1b и v1a рецепторов | |
| MX9303966A (es) | Derivados de benzotiazepina y benzoxazepina. | |
| DE69810959D1 (de) | Verfahren zur herstellung von pyrrolamiden | |
| ES8702379A1 (es) | Un procedimiento para la produccion de 1h-tetrazol-5-carboxamidas-n-sustituidas. | |
| ATE212961T1 (de) | Verfahren zur herstellung von ethinylcyclopropan | |
| BRPI0417147A (pt) | processo para preparação de derivados de (3-oxo-2,3-dihidro-1h-isoindol-1-il)-acetilguanidinas |